Abstract
Background: Not only have antibiotics saved countless patients' lives but they have also
played a crucial role in supporting major advances in modern medicine. However,
precipitously emerging resistant bacterial strains jeopardise the remarkable advances
achieved with antibiotics. In the past, the development of new antibiotics was an effective
strategy to combat resistant bacteria. However, with the discovery of new antibiotics
diminishing, optimising the administration of currently available antibiotics has become a
necessity. A strategy of particular interest involves applying pharmacokinetic and
pharmacodynamic concepts to optimise time-dependant antibiotics dosing regimens. The
latter is a growing area of interest for reducing the development of antibiotic resistance, and
it involves differential dosing regimens such as prolonged or continuous infusions of beta-lactam antibiotics.
Aim: The overarching aim of this research is to optimise antibiotic therapy for inpatient and
outpatient use.
This thesis consists of literature-based, practice-based, and laboratory-based research.
Literature-based: The aim of the literature-based research category was to review existing
literature to compare the clinical outcomes of continuous vs intermittent infusion beta-lactam antibiotics and appraise the strengths and the weaknesses of current evidence.
Overall, literature-based research demonstrated a wealth of studies in terms of systematic
reviews, meta-analysis as well as primary studies. Despite the literature exhibiting
favourable outcomes towards prolonged/continuous infusions, the literature review and
systematic reviews conducted support the need for better conducted, definitive trials and
systematic reviews given the variability in scope of the available studies.
Practice-based: The aim of the practice-based research category was to provide a snapshot
of beta-lactam antibiotic use in clinical practice. The first study was single-centre
retrospective cohort practice review conducted to Investigate the prescribing patterns of
beta-lactam antibiotics in critical care wards. The second study was a cross sectional survey
investigating nurse's knowledge, perceptions, and experiences regarding differential
antibiotic dosing. Findings show that prolonged/continuous infusions as dosing strategies
are implemented in practice to improve patient outcomes, however, healthcare
XI
professionals implementing this practice have not received sufficient training to support the
administration of differential antibiotic dosing. This was evident from both practice based
studies that disclose beta-lactam antibiotics are not used to their full potential or are
inaccurately used. There is a need for tailored education and training to improve health care
professional's knowledge of prolonged/continuous infusions.
Laboratory-based: Despite the advantages that prolonged/continuous infusions beta-lactam
antibiotics offer, in order to use these dosing regimens efficiently, infusion solutions should
remain stable for the preparation, storage and infusion time. Concerns regarding stability
present a challenge in practice as most stability information is based on administration via
bolus injection or an intermittent infusion. Therefore, the aim of the laboratory-based
research category was to determine the feasibility of prolonged/continuous infusion beta-lactam antibiotics for hospital and outpatient settings. Findings from the conducted studies
aid in ameliorating current dosing regimens to optimise antibiotic efficacy. Results obtained
from stability studies assist in resolving challenges experienced in practice in terms of
preparation, storage, and administration as they indicate the effects of temperature,
diluent, and pre-preparation of infusion solutions. Studies demonstrated that stability data
generated in all studies are an improvement to the stability data presented in the British,
American, and European pharmacopoeias.
Conclusion: Findings of this PhD research are supportive of the beneficial role of differential
antibiotic dosing. Overall, the gathered data indicate that prolonged/continuous infusions
are feasible, advantageous and could potentially improve patient clinical outcomes.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy (PhD) |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Publication status | Accepted/In press - Aug 2021 |
Bibliographical note
Physical Location: Online Only.Keywords
- antibiotic resistance
- beta-lactam antibiotic
- beta-lactamase inhibitor
- differential antibiotic dosing
- stability
- continuous infusion
- prolonged infusion
- intermittent infusion
- piperacillin
- tazobactam
- amoxicillin
- clavulanic acid
- Pharmacy
PhD type
- Standard route